The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver Disease

참고문헌 (10)

1. Wong VW, "Changing epidemiology, global trends and implications for outcomes of NAFLD", J Hepatol, 79, pp.842~852 (2023)
2. Konyn P, "Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease", Clin Mol Hepatol, 29(Suppl), pp.S43~S57 (2023)
3. Sanyal AJ, "Prospective study of outcomes in adults with nonalcoholic fatty liver disease", N Engl J Med, 385, pp.1559~1569 (2021)
4. Sookoian S, "Systematic review with meta-analysis : the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease", Aliment Pharmacol Ther, 47, pp.16~25 (2018)
5. Koo BK, "Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis", J Hepatol, 66, pp.123~131 (2017)
6. Han E, "Appendicular skeletal muscle mass to visceral fat area ratio predicts hepatic morbidities", Gut Liver, 18, pp.509~519 (2024)
7. Yu JH, "Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease : current and future", Clin Mol Hepatol, 29(Suppl), pp.S136~S149 (2023)
8. Hsieh YC, "Myosteatosis, but not sarcopenia, predisposes NAFLD subjects to early steatohepatitis and fibrosis progression", Clin Gastroenterol Hepatol, 21, pp.388~397 (2023)
9. Kang S, "Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease : a Korean nationwide survey", J Cachexia Sarcopenia Muscle, 11, pp.1232~1241 (2020)
10. Singh S, "Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis : a systematic review and metaanalysis of paired-biopsy studies", Clin Gastroenterol Hepatol, 13, pp.643~654 (2015)

관련 논문AI추천